Patrick Wildman is Vice President of Advocacy & Government Relations for the Lupus Foundation of America. In this role, Pat is responsible for developing and implementing strategies to advance the Foundation’s public policy priorities. This includes leading the Foundation’s interaction with government officials and agencies and handling legislative and regulatory issues related to the Centers for Medicare and Medicaid Services, the Food and Drug Administration, the Centers for Disease Control and Prevention, the National Institutes of Health, the Social Security Administration, Department of Defense and Department of Veterans Affairs. Pat also oversees the Foundation’s Patient Focused Drug Development efforts including working with the Lupus and Allied Diseases Association, the Lupus Research Alliance and the FDA to host an externally-led PFDD meeting. Pat has over 20 years of legislative and regulatory policy and advocacy experience, including as staff for a Member of Congress and at The ALS Association as Senior Vice President of Public Policy where he led the organization’s federal legislative and regulatory policy program. While at The ALS Association, Pat oversaw several PFDD initiatives, including the development of a patient-led Draft Guidance for ALS drug development and partnering with FDA to host a Part 15 Public Hearing on ALS. A native of Massachusetts, Pat received his B.A. from Dartmouth College.